等待開盤 01-28 09:30:00 美东时间
+0.630
+0.18%
今日重点评级关注:HC Wainwright & Co.:上调Tempest Therapeutics评级至"买入",目标价11美元;Guggenheim:维持Sportradar Gr"买入"评级,目标价从34美元升至35美元
01-23 19:46
Jefferies analyst Brian Tanquilut upgrades Cencora (NYSE:COR) from Hold to Buy and raises the price target from $330 to $440.
01-22 21:19
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 9.56% ...
01-20 05:45
今日重点评级关注:HC Wainwright & Co.:维持Assertio Holdings"买入"评级,目标价从3美元升至35美元;HC Wainwright & Co.:维持万达生物制药"买入"评级,目标价从20美元升至22美元
01-06 17:52
B of A Securities analyst Michael Funk maintains Cencora (NYSE:COR) with a Neutral and lowers the price target from $380 to $360.
01-05 21:29
Cramer said, although he likes Cencora, Cardinal Health Inc. has "got them all beat." Plus: Perpetua Resources is a "hot," but...
2025-12-16 21:17
Cencora agrees to buy a majority stake in OneOncology for about $5 billion, pauses buybacks, and reiterates fiscal 2026 sales and EPS guidance.
2025-12-15 22:09
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从12美元升至13美元;Guggenheim:维持Praxis Precision Medicine"买入"评级,目标价从540美元升至760美元
2025-12-10 10:33
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
2025-11-12 11:43